| Date Filed | Type | Description |
| 01/05/2023 |
4
| Arthur David J. (CEO) has filed a Form 4 on Salarius Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 shares
@ $0 |
|
| 12/12/2022 |
4/A
| Arthur David J. (CEO) has filed a Form 4 on Salarius Pharmaceuticals, Inc.|
Txns:
| Granted 2,693 shares
@ $1.734, valued at
$4.7k
|
|
| 11/08/2022 |
4/A
| Arthur David J. (CEO) has filed a Form 4 on Salarius Pharmaceuticals, Inc.|
Txns:
| Granted 10,000 shares
@ $1.734, valued at
$17.3k
|
|
| 11/07/2022 |
4
| Arthur David J. (CEO) has filed a Form 4 on Salarius Pharmaceuticals, Inc.|
Txns:
| Granted 10,000 shares
@ $1.734, valued at
$17.3k
|
|
| 05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/21/2022 |
4
| Arthur David J. (CEO) has filed a Form 4 on Salarius Pharmaceuticals, Inc.|
Txns:
| Granted 500,000 options to buy
@ $0.48, valued at
$240k
|
|
| 11/05/2021 |
4
| Arthur David J. (CEO) has filed a Form 4 on Salarius Pharmaceuticals, Inc.|
Txns:
| Granted 7,939 shares
@ $0.718, valued at
$5.7k
|
|
| 08/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/04/2020 |
4
| Arthur David J. (CEO) has filed a Form 4 on Salarius Pharmaceuticals, Inc.|
Txns:
| Granted 275,000 options to buy
@ $0.74, valued at
$203.5k
|
|
| 11/05/2020 |
4
| Arthur David J. (CEO) has filed a Form 4 on Salarius Pharmaceuticals, Inc.|
Txns:
| Granted 4,879 shares
@ $0.561, valued at
$2.7k
|
|
| 08/20/2020 |
4
| Arthur David J. (CEO) has filed a Form 4 on Salarius Pharmaceuticals, Inc.|
Txns:
| Bought 1,000 shares
@ $1.01, valued at
$1k
|
|
| 07/16/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/25/2020 |
4
| Arthur David J. (CEO) has filed a Form 4 on Salarius Pharmaceuticals, Inc.|
Txns:
| Granted 60,000 options to buy
@ $0.61, valued at
$36.6k
|
|
| 02/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/13/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/23/2019 |
3
| Arthur David J. (CEO) has filed a Form 3 on Salarius Pharmaceuticals, Inc. |